Literature DB >> 18632295

Nucleoside reverse transcriptase inhibitor resistance mutations in subtype F1 strains isolated from heavily treated adolescents in Romania.

Simona Paraschiv1, Dan Otelea, Cristian Baicus, Mihaela Tinischi, Marieta Costache, Emil Neaga.   

Abstract

OBJECTIVE: To examine the nucleoside reverse transcriptase inhibitor (NRTI) resistance mutations in the reverse transcriptase gene of HIV-1 F1 subtype strains isolated from heavily treated adolescents.
METHODS: Three hundred and fifty reverse transcriptase (RT) genotypes with at least three NRTI resistance mutations were included in this study; the corresponding strains were isolated from adolescents with a complex history of antiretroviral treatment. Subtyping was done using the publicly available algorithm REGA HIV-1&2. Resistance genotyping was performed using Big Dye Terminator chemistry provided by the ViroSeq genotyping system. The RT gene carrying the K65R mutation and thymidine analog mutations (TAMs) was cloned into pGEM-T vector (Promega), followed by sequencing. In order to identify mutational clusters we calculated the binomial (phi) correlation coefficient using SPSS 11.0 software.
RESULTS: The analyzed sequences all belonged to the F1 subtype and were frequently carrying TAMs associated with substitutions at position 184. TAM-2 was the pathway more frequently encountered, and the demarcation between TAM-1 and TAM-2 was rather weak. Although the combination of K65R mutation with TAMs has rarely been reported because of their antagonistic effects on NRTI resistance, its presence was confirmed by clonal analysis of one strain. Four percent of the studied genotypes presented insertions and deletions in the region 67-70 of the RT gene and they were frequently associated with particular TAMs. Most of the NRTI resistance mutations were found to belong to one of three distinct clusters.
CONCLUSION: Although the overall resistance mutations were not different from those described for subtype B, the subtype F1 HIV-1 NRTI mutation patterns displayed same specificities with possible therapeutic consequences.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18632295     DOI: 10.1016/j.ijid.2008.03.032

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  2 in total

1.  Use of Proviral DNA to Investigate Virus Resistance Mutations in HIV-infected Zimbabweans.

Authors:  Tutsirai V Musingwini; Danai T Zhou; Doreen Mhandire; Kerina Duri; Exnevia Gomo; Olav Oktedalen; Benjamin Chimukangara; Tinei Shamu; Sandra Shawarira-Bote; Collet Dandara; Babill Stray-Pedersen
Journal:  Open Microbiol J       Date:  2017-04-28

Review 2.  Romania, a Harbour of HIV-1 Subtype F1: Where Are We after 33 Years of HIV-1 Infection?

Authors:  Mădălina Preda; Loredana Cornelia Sabina Manolescu
Journal:  Viruses       Date:  2022-09-19       Impact factor: 5.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.